<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04593667</url>
  </required_header>
  <id_info>
    <org_study_id>WIRB Protocol 20202766</org_study_id>
    <secondary_id>1291856</secondary_id>
    <nct_id>NCT04593667</nct_id>
  </id_info>
  <brief_title>Randomized Study of Accelerated Radial Arterial Hemostasis</brief_title>
  <acronym>GOLOW</acronym>
  <official_title>Utilizing a Novel Agent in a Randomized Study of Accelerated Radial Arterial Hemostasis Under Reduced Compression Following Percutaneous Transradial Coronary Angiography/Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medcura Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medcura Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical randomized study to evaluate the effect of using a hydrophobically modified&#xD;
      polysaccharide (hm-P) bandage&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will evaluate the clinical performance (e.g. hemostatic and patient outcomes) of&#xD;
      this hm-P bandage by using an earlier time for removal of the bandage (e.g. 60 minutes) than&#xD;
      the current standard of care (e.g. 90-180 minutes) while also reducing the inflated pressure&#xD;
      of the band, and hence the compressive force put on the wrist of the patient, in increments&#xD;
      of the % of inflation as per current protocol, with N=20 @ 100%, N=20 @ 75%, &amp; N=20 @ 50%.&#xD;
      This study will be completed while maintaining vascular integrity and patency through&#xD;
      visualization in patients undergoing angiographic procedures via anticoagulated, percutaneous&#xD;
      radial arterial cannulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 9, 2020</start_date>
  <completion_date type="Actual">July 14, 2021</completion_date>
  <primary_completion_date type="Actual">December 9, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>60 patients, randomized into one of three arms</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to hemostasis</measure>
    <time_frame>60 minutes</time_frame>
    <description>Significant change in time to hemostasis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compressive Force</measure>
    <time_frame>60 minutes</time_frame>
    <description>Change in the compressive force onto the access site</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radial Artery</measure>
    <time_frame>immediately after hemostasis</time_frame>
    <description>Evaluation of the radial artery post hemostasis by visual or reverse Barbeau test</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Hemostasis</condition>
  <arm_group>
    <arm_group_label>Full Inflation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>100% TR Band inflation relative to recommended inflation with 15-18 cc air injected in TR band bladder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mid Inflation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>75% TR Band inflation relative to recommended inflation with 11-14 cc air injected in TR band bladder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Inflation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>50% TR Band inflation relative to recommended inflation with 8-9 cc air injected in TR band bladder</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hm-P bandage</intervention_name>
    <description>hm-P bandage will be placed over the puncture site with the TR band positioned over the hemostatic bandage. The TR band will then be inflated per device specific instructions and to the group instructions. The arterial sheath will be removed from the body with slight device rotation.</description>
    <arm_group_label>Full Inflation</arm_group_label>
    <arm_group_label>Low Inflation</arm_group_label>
    <arm_group_label>Mid Inflation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Current patients who are undergoing diagnostic and interventional coronary/vascular&#xD;
             angiography via a transradial approach with or without planned coronary or peripheral&#xD;
             intervention.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Varinder Singh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwell Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lenox Hill Hospital - Northwell Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 7, 2020</study_first_submitted>
  <study_first_submitted_qc>October 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

